Allscripts Enacts Poison Pill Following Stock Value Drop
The so-called stockholder rights plan was not adopted in response to any current takeover bids, the company said. When asked Monday if Allscripts was responding to any specific threats on the horizon, spokeswoman Ariana Nikitas told Law360 that Allscripts' policy is not to comment on rumors of that nature.
The poison pill, which will expire in May...
To view the full article, register now.